000			01620 a2200433 4500
005			20250517110223.0
264		0	_c20170407
008			201704s 0 0 eng d
022			_a1878-1705
024	7		_a10.1016/j.intimp.2016.07.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Hongli
245	0	0	_aDopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. _h[electronic resource]
260			_bInternational immunopharmacology _cOct 2016
300			_a113-120 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinogenesis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDopamine _xtherapeutic use
650	0	4	_aEpidermal Growth Factor _xmetabolism
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMatrix Metalloproteinase 13 _xmetabolism
650	0	4	_aOncogene Protein v-akt _xmetabolism
650	0	4	_aReceptors, Dopamine D2 _xagonists
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aStomach Neoplasms _xdrug therapy
700	1		_aWu, Kaiming
700	1		_aMa, Jun
700	1		_aDu, Yanlei
700	1		_aCao, Chuangyu
700	1		_aNie, Yuqiang
773	0		_tInternational immunopharmacology _gvol. 39 _gp. 113-120
856	4	0	_uhttps://doi.org/10.1016/j.intimp.2016.07.002 _zAvailable from publisher's website
999			_c26275096 _d26275096